Caudill Cortney

Track

Insider profile

Performance

Overall performance
2.0
Performance over holding periods
2.0
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 88% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Caudill Cortney's trades of Halozyme Therapeutics, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
370.93
Quantity 48,301
Value US$48,997
Transaction date
Proposed sale
Price
482.40
Quantity 81,775
Value US$1,724,016
Transaction date
Proposed sale
Price
67.80
Quantity 20,000
Value US$1,356,062
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-11 2026-08-11
PrS Proposed sale
48,301
370.93
US$48,997 		48,301 370.93 US$48,997
2026-03-10 2026-03-10
PrS Proposed sale
81,775
482.40
US$1,724,016 		81,775 482.40 US$1,724,016
2026-03-10 2026-03-10
S Sale
76,239 -13.3%
81.24
US$4,784,555 		76,239 -13.3% 81.24 US$4,784,555
2026-03-10 2026-03-09
S Sale
2,100 -12.8%
68.25
US$143,329 		2,100 -12.8% 68.25 US$143,329
2026-03-10 2026-03-09
S Sale
17,900 -52.1%
67.75
US$1,212,743 		17,900 -52.1% 67.75 US$1,212,743
2026-03-09 2026-03-09
PrS Proposed sale
20,000
67.80
US$1,356,062 		20,000 67.80 US$1,356,062
2025-12-19 2025-11-01
S Sale
4,263 -25.1%
65.19
US$277,905 		4,263 -25.1% 65.19 US$277,905